[Elsevier] Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial |
|
This post will be closed automatically in 2026-11-04 12:07
Reward10points
|
30
https://www.sciencedirect.com/journal/structural-safety/vol/117/suppl/C
30
https://www.sciencedirect.com/journal/structural-safety/vol/116/suppl/C
30
https://www.sciencedirect.com/journal/structural-safety/vol/114/suppl/C
30
Unmasking the genetic heterogeneity of cystic fibrosis in the Torbat Jam region: From common variants to large deletions and the challenge of missing heritability
30
https://www.sciencedirect.com/journal/structural-safety/vol/113/suppl/C
